In a filing, Apimeds Pharmaceuticals US Inc revealed its Chairman and CMO Kim Christopher acquired Company’s shares for reported $35981.0 on May 13 ’25. In the deal valued at $1.82 per share,19,770 shares were bought. As a result of this transaction, Kim Christopher now holds 19,770 shares worth roughly $34597.5.
Then, Kim Christopher bought 7,730 shares, generating $14,378 in total proceeds. Upon buying the shares at $1.86, the Chairman and CMO now owns 27,500 shares.
Before that, Koo Jakap bought 28,500 shares. Apimeds Pharmaceuticals US Inc shares valued at $56,715 were divested by the Director at a price of $1.99 per share. As a result of the transaction, Koo Jakap now holds 643,885 shares, worth roughly $1.13 million.
Price Performance Review of APUS
On Monday, Apimeds Pharmaceuticals US Inc [AMEX:APUS] saw its stock jump 9.37% to $1.75. Over the last five days, the stock has gained 14.38%. Nevertheless, the stocks have fallen -20.45% over the past one year.
Levels Of Support And Resistance For APUS Stock
The 24-hour chart illustrates a support level at 1.5367, which if violated will result in even more drops to 1.3233. On the upside, there is a resistance level at 2.0167. A further resistance level may holdings at 2.2833.
How much short interest is there in Apimeds Pharmaceuticals US Inc?
A steep rise in short interest was recorded in Apimeds Pharmaceuticals US Inc stocks on 2025-07-31, growing by 18575.0 shares to a total of 19766.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 1191.0 shares. There was a rise of 93.97%, which implies that there is a positive sentiment for the stock.
